AstraZeneca PLC (LON:AZN)

AstraZeneca Revenue

AstraZeneca had revenue of $15.38B USD in the quarter ending June 30, 2026, with 6.41% growth. This brings the company's total for the last twelve months to $61.37B, up 8.61% year-over-year. In the year 2025, AstraZeneca had annual revenue of $58.74B with 8.63% growth. That makes AstraZeneca the 198th largest company in the world by revenue and 7th in the United Kingdom.

• Revenue (ttm): $61.37B
• Revenue Growth: +8.61%
• P/S Ratio: 4.30
• Revenue / Employee: $638.56K
• Employees: 96,100
• Market Cap: 197.97B GBP

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Oncology 25.62B 43.6%
• BioPharmaceuticals: Cardiovascular, Renal & Metabolism PR (CVRM) 12.77B 21.7%
• Rare Disease 9.13B 15.5%
• BioPharmaceuticals: Respiratory & Immunology PR (R&I) 8.87B 15.1%
• BioPharmaceuticals Infectious Disease PR (ID) 1.27B 2.2%
• Other Medicines 988.00M 1.7%
• Collaboration 99.00M 0.2%

By Geography

Chart

• The Americas 27.56B 46.9%
• Rest of Europe 13.46B 22.9%
• Asia, Africa & Australasia 13.37B 22.8%
• UK 4.36B 7.4%

Fiscal year ended Dec 31, 2025 See the full AstraZeneca breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	58.74B	4.67B	8.63%
Dec 31, 2024	54.07B	8.26B	18.03%
Dec 31, 2023	45.81B	1.46B	3.29%
Dec 31, 2022	44.35B	6.93B	18.53%
Dec 31, 2021	37.42B	10.80B	40.58%
Dec 31, 2020	26.62B	2.23B	9.16%
Dec 31, 2019	24.38B	2.29B	10.38%
Dec 31, 2018	22.09B	-375.00M	-1.67%
Dec 31, 2017	22.47B	-537.00M	-2.33%
Dec 31, 2016	23.00B	-1.71B	-6.90%
Dec 31, 2015	24.71B	-1.84B	-6.93%
Dec 31, 2014	26.55B	741.00M	2.87%
Dec 31, 2013	25.81B	-2.17B	-7.75%
Dec 31, 2012	27.97B	-5.62B	-16.72%
Dec 31, 2011	33.59B	322.00M	0.97%
Dec 31, 2010	33.27B	465.00M	1.42%
Dec 31, 2009	32.80B	1.20B	3.81%
Dec 31, 2008	31.60B	2.04B	6.91%
Dec 31, 2007	29.56B	3.08B	11.65%
Dec 31, 2006	26.48B	2.53B	10.54%
Dec 31, 2005	23.95B	-	-

Data Source: Fiscal.ai Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error